Search clinical trials for: Lumenis Pulse P120H and Xpeeda side firing fiber
Total 2 results
-
Lumenis Be Ltd.UnknownTreatment of Benign Prostatic HyperplasiaUnited States
-
Lumenis Be Ltd.UnknownStone ClearanceUnited States
Sponsors and Collaborators
- IRCCS Don Gnocchi, Milano, Italy
- Korrus Inc.
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- HeartPoint Global
- Gulsah Ilhan
- Michael J. Wesley, PhD
- Laboratorios Viñas, S.A.
- Ruba Musharbash Nutrition Consultancy Center
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- King Baudouin Foundation
- Frankel, Amylynne, M.D.
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Army Hospital, Percy
- Ana Paula Costella
- Pharmaspecific
- Walgreens Co.
- Edanz Group Japan Ltd
- Fundación Pública Andaluza Progreso y Salud
- Center for Rare Neurological Diseases, Norcross, GA
- Manmohan Cardiothoracic Vascular and Transplant Center
- View Full List
Medical Conditions
- Facial Involvement
- Pelvis Tumors
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Lung Neuroendocrine Tumor
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Cardiovascular Outcomes
- Impairment, Coordination
- Gastroenteritis Rotavirus
- Cognitive Function, Social 1
- Brain Arteriovenous Malformation
- Localized Unresectable Adult Primary Liver Cancer
- Ankylosed Teeth
- Menopause
- Kidney Damage
- Coagulation Disorder Neonatal
- Uncontrolled Type 2 Diabetes Mellitus
- Malignant Intracranial Germ Cell Tumor
- Paralysis of Vocal Cords or Larynx
- Developmental Language Disorder and Language Impairment
- Severe Atopic Dermatitis
- View Full List
Drug Interventions
- 5-Fluorouracil
- Interferon beta-1b (Betaferon, BAY86-5046)
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Lidocaine/ ketamine
- Exendin 9-39
- Apremilast
- Interleukin-2
- FHND5071
- Extended release guanfacine
- Insulin
- Rituximab plus CHOP
- Thiotepa
- CD25 treatment
- Dexmedetomidine
- Ozanimod
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- Miglustat
- Methotrexate
- LDEPA
- Transdermal estradiol
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Austria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Chile
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Finland
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Latvia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Africa
- CRO list by country